Cargando…
COVID -19: From the Molecular Mechanisms to Treatment
The 2019 novel coronavirus (SARS-CoV-2) causes severe pneumonia called COVID-19 and leads to severe acute respiratory syndrome with a high mortality rate. The SARS-CoV-2 virus in the human body leads to jumpstarting immune reactions and multi-organ inflammation, which has poorer outcomes in the pres...
Autores principales: | Habibzadeh, Shahram, Hashemzadeh, Nastaran, Baradaran, Hananeh, Razi Soofiyani, Saiedeh, Jadideslam, Golamreza, Pahlavan, Yasamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985119/ https://www.ncbi.nlm.nih.gov/pubmed/36879738 |
Ejemplares similares
-
Current and Novel Emerging Medical Therapies for Peripheral Artery Disease: A Literature Review
por: Arabzadeh, AmirAhmad, et al.
Publicado: (2023) -
Gene therapy based on interleukin-12 loaded chitosan nanoparticles in a mouse model of fibrosarcoma
por: Soofiyani, Saiedeh Razi, et al.
Publicado: (2016) -
Colorectal cancer treatment using bacteria: focus on molecular mechanisms
por: Ebrahimzadeh, Sara, et al.
Publicado: (2021) -
siRNA-Mediated Silencing of CIP2A Enhances Docetaxel Activity Against PC-3 Prostate Cancer Cells
por: Razi Soofiyani, Saiedeh, et al.
Publicado: (2017) -
Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy
por: Derakhshani, Afshin, et al.
Publicado: (2021)